New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

Toboso, I; Tejeda-Velarde, A; Alvarez-Lafuente, R; Arroyo, R; Hegen, H; Deisenhammer, F; de la Maza, SS; Alvarez-Cermeno, JC; Izquierdo, G; Paramo, D; Oliva, P; Casanova, B; Aguera-Morales, E; Franciotta, D; Gastaldi, M; Fernandez, O; Urbaneja, P; Garcia-Dominguez, JM; Romero, F; Laroni, A; Uccelli, A; Perez-Sempere, A; Saiz, A; Blanco, Y; Galimberti, D; Scarpini, E; Espejo, C; Montalban, X; Rasche, L; Paul, F; Gonzalez, I; Alvarez, E; Ramo, C; Caminero, AB; Aladro, Y; Calles, C; Eguia, P; Belenguer-Benavides, A; Ramio-Torrenta, L; Quintana, E; Martinez-Rodriguez, JE; Oterino, A; de Silanes, CL; Casanova, LI; Landete, L; Frederiksen, J; Bsteh, G; Mulero, P; Comabella, M; Hernandez, MA; Espino, M; Prieto, JM; Perez, D; Otano, M; Padilla, F; Garcia-Merino, JA; Navarro, L; Muriel, A; Frossard, LC; Villar, LM – 2020